Heat shock protein vaccines against glioblastoma: from bench to bedside
about
History and current state of immunotherapy in glioma and brain metastasis.An Update on the Role of Immunotherapy and Vaccine Strategies for Primary Brain Tumors.Advances in HSP27 and HSP90-targeting strategies for glioblastoma.Tumor-derived factors modulating dendritic cell function.Vaccine-based immunotherapeutic approaches to gliomas and beyond.The Kynurenine/Tryptophan Ratio and Glioblastoma Patients Treated with Hsppc-96 Vaccine.Investigational new drugs for brain cancer.Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.Immunological Aspects of Malignant Gliomas.Immunotherapy approaches in the treatment of malignant brain tumors.The Safety of available immunotherapy for the treatment of glioblastoma.Treatment options for recurrent high-grade gliomas.Tumor Vaccines for Malignant Gliomas.HSP70-based anti-cancer immunotherapy.Vaccination in the immunotherapy of glioblastoma.Magnetic hyperthermia therapy for the treatment of glioblastoma: a review of the therapy's history, efficacy, and application in humans.Towards personalized, tumour-specific, therapeutic vaccines for cancer.HSP70L1-mediated intracellular priming of dendritic cell vaccination induces more potent CTL response against cancer.Novel Immunotherapeutics for the Treatment of Glioblastoma: The Last Decade of Research.
P2860
Q33656811-EA44D045-9C01-412A-848E-8F0B6E51F90AQ38603909-2277E896-083F-4077-8714-86FD292E3C27Q38722149-7E348DBB-90BF-46D7-BD56-8B5CBE24B9F4Q38777795-5F7ABA69-DB35-4D2C-A1A4-82F0C252A764Q38789860-2773E5B1-259E-4A04-AA26-FF2780C84A50Q38797946-A21EA598-C9BB-472C-A56A-ABAEEF163120Q38832510-A625F219-AE40-4070-A02B-5A65630B71F1Q38849515-95071FF0-83B8-44AF-83A6-E527A5D1B9E8Q38870994-903ACAC5-031C-4CD4-867A-975EE9DDC29FQ39016790-A7A7D8DC-27E1-4F3A-A908-1AA44F41784BQ39042442-686199FA-4A68-43C1-A16D-D107592FED5DQ39045968-7EBB3A2A-FA4D-48E6-9377-375AF3E106F4Q39228039-9EF2E08E-63A9-45DC-AC55-0DCC53C4629CQ39688737-D2F7B299-8CAC-4848-8BB4-EA3B7F2E5A0CQ47583155-571E0170-06DC-4BEB-A0B9-0BB3BD62E203Q47721799-FC06DB17-E46E-4760-84B6-6A2A7AB169C4Q47789519-9FE9D42F-E4F0-4EFA-96C9-8AD10F1A1367Q51680693-5ED89483-138F-41B9-A85D-904B6A73ECB6Q52564518-C7A67638-E819-477E-8EBA-598B93FE9DE4
P2860
Heat shock protein vaccines against glioblastoma: from bench to bedside
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Heat shock protein vaccines against glioblastoma: from bench to bedside
@ast
Heat shock protein vaccines against glioblastoma: from bench to bedside
@en
Heat shock protein vaccines against glioblastoma: from bench to bedside
@nl
type
label
Heat shock protein vaccines against glioblastoma: from bench to bedside
@ast
Heat shock protein vaccines against glioblastoma: from bench to bedside
@en
Heat shock protein vaccines against glioblastoma: from bench to bedside
@nl
prefLabel
Heat shock protein vaccines against glioblastoma: from bench to bedside
@ast
Heat shock protein vaccines against glioblastoma: from bench to bedside
@en
Heat shock protein vaccines against glioblastoma: from bench to bedside
@nl
P2093
P2860
P3181
P1476
Heat shock protein vaccines against glioblastoma: from bench to bedside
@en
P2093
Andrew T. Parsa
Jonathan B. Lamano
Leonel Ampie
Orin Bloch
Shayan Fakurnejad
Winward Choy
P2860
P2888
P3181
P356
10.1007/S11060-015-1837-7
P407
P577
2015-07-01T00:00:00Z
P6179
1043321148